Global mRNA Vaccines and Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The Global mRNA Vaccines and Therapeutics Market Size was estimated at USD 3902.22 million in 2023 and is projected to reach USD 1578.71 million by 2029, exhibiting a CAGR of -14.00% during the forecast period.
This report provides a deep insight into the global mRNA Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccines and Therapeutics market in any manner.
Global mRNA Vaccines and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccines
Market Segmentation (by Application)
Infectious Disease
Cancer
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The Global mRNA Vaccines and Therapeutics Market Size was estimated at USD 3902.22 million in 2023 and is projected to reach USD 1578.71 million by 2029, exhibiting a CAGR of -14.00% during the forecast period.
This report provides a deep insight into the global mRNA Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccines and Therapeutics market in any manner.
Global mRNA Vaccines and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market Segmentation (by Type)
Infectious Disease Vaccines
Cancer Vaccines
Market Segmentation (by Application)
Infectious Disease
Cancer
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the mRNA Vaccines and Therapeutics Market
- Overview of the regional outlook of the mRNA Vaccines and Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccines and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 mRNA Vaccines and Therapeutics Segment by Type
1.2.2 mRNA Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINES AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINES AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 mRNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 mRNA Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINES AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINES AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccines and Therapeutics Price by Type (2019-2024)
7 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines and Therapeutics Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
8 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Moderna Therapeutics
9.1.1 Moderna Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.1.4 Moderna Therapeutics Business Overview
9.1.5 Moderna Therapeutics mRNA Vaccines and Therapeutics SWOT Analysis
9.1.6 Moderna Therapeutics Recent Developments
9.2 CureVac
9.2.1 CureVac mRNA Vaccines and Therapeutics Basic Information
9.2.2 CureVac mRNA Vaccines and Therapeutics Product Overview
9.2.3 CureVac mRNA Vaccines and Therapeutics Product Market Performance
9.2.4 CureVac Business Overview
9.2.5 CureVac mRNA Vaccines and Therapeutics SWOT Analysis
9.2.6 CureVac Recent Developments
9.3 Translate Bio
9.3.1 Translate Bio mRNA Vaccines and Therapeutics Basic Information
9.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Overview
9.3.3 Translate Bio mRNA Vaccines and Therapeutics Product Market Performance
9.3.4 Translate Bio mRNA Vaccines and Therapeutics SWOT Analysis
9.3.5 Translate Bio Business Overview
9.3.6 Translate Bio Recent Developments
9.4 BioNTech
9.4.1 BioNTech mRNA Vaccines and Therapeutics Basic Information
9.4.2 BioNTech mRNA Vaccines and Therapeutics Product Overview
9.4.3 BioNTech mRNA Vaccines and Therapeutics Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech Recent Developments
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.5.4 Sangamo Therapeutics Business Overview
9.5.5 Sangamo Therapeutics Recent Developments
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.6.4 Argos Therapeutics Business Overview
9.6.5 Argos Therapeutics Recent Developments
9.7 In-Cell-Art
9.7.1 In-Cell-Art mRNA Vaccines and Therapeutics Basic Information
9.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Overview
9.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Product Market Performance
9.7.4 In-Cell-Art Business Overview
9.7.5 In-Cell-Art Recent Developments
9.8 eTheRNA
9.8.1 eTheRNA mRNA Vaccines and Therapeutics Basic Information
9.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Overview
9.8.3 eTheRNA mRNA Vaccines and Therapeutics Product Market Performance
9.8.4 eTheRNA Business Overview
9.8.5 eTheRNA Recent Developments
9.9 Ethris
9.9.1 Ethris mRNA Vaccines and Therapeutics Basic Information
9.9.2 Ethris mRNA Vaccines and Therapeutics Product Overview
9.9.3 Ethris mRNA Vaccines and Therapeutics Product Market Performance
9.9.4 Ethris Business Overview
9.9.5 Ethris Recent Developments
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology mRNA Vaccines and Therapeutics Basic Information
9.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Overview
9.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Market Performance
9.10.4 Tiba Biotechnology Business Overview
9.10.5 Tiba Biotechnology Recent Developments
10 MRNA VACCINES AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global mRNA Vaccines and Therapeutics Market Size Forecast
10.2 Global mRNA Vaccines and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccines and Therapeutics Market Size Forecast by Region
10.2.4 South America mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccines and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global mRNA Vaccines and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.1.2 Global mRNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.2 Global mRNA Vaccines and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccines and Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 mRNA Vaccines and Therapeutics Segment by Type
1.2.2 mRNA Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA VACCINES AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA VACCINES AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global mRNA Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 mRNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 mRNA Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRNA VACCINES AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 mRNA Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA VACCINES AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccines and Therapeutics Price by Type (2019-2024)
7 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccines and Therapeutics Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
8 MRNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.1 Global mRNA Vaccines and Therapeutics Sales by Region
8.1.2 Global mRNA Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Moderna Therapeutics
9.1.1 Moderna Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.1.4 Moderna Therapeutics Business Overview
9.1.5 Moderna Therapeutics mRNA Vaccines and Therapeutics SWOT Analysis
9.1.6 Moderna Therapeutics Recent Developments
9.2 CureVac
9.2.1 CureVac mRNA Vaccines and Therapeutics Basic Information
9.2.2 CureVac mRNA Vaccines and Therapeutics Product Overview
9.2.3 CureVac mRNA Vaccines and Therapeutics Product Market Performance
9.2.4 CureVac Business Overview
9.2.5 CureVac mRNA Vaccines and Therapeutics SWOT Analysis
9.2.6 CureVac Recent Developments
9.3 Translate Bio
9.3.1 Translate Bio mRNA Vaccines and Therapeutics Basic Information
9.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Overview
9.3.3 Translate Bio mRNA Vaccines and Therapeutics Product Market Performance
9.3.4 Translate Bio mRNA Vaccines and Therapeutics SWOT Analysis
9.3.5 Translate Bio Business Overview
9.3.6 Translate Bio Recent Developments
9.4 BioNTech
9.4.1 BioNTech mRNA Vaccines and Therapeutics Basic Information
9.4.2 BioNTech mRNA Vaccines and Therapeutics Product Overview
9.4.3 BioNTech mRNA Vaccines and Therapeutics Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech Recent Developments
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.5.4 Sangamo Therapeutics Business Overview
9.5.5 Sangamo Therapeutics Recent Developments
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics mRNA Vaccines and Therapeutics Basic Information
9.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Overview
9.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Product Market Performance
9.6.4 Argos Therapeutics Business Overview
9.6.5 Argos Therapeutics Recent Developments
9.7 In-Cell-Art
9.7.1 In-Cell-Art mRNA Vaccines and Therapeutics Basic Information
9.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Overview
9.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Product Market Performance
9.7.4 In-Cell-Art Business Overview
9.7.5 In-Cell-Art Recent Developments
9.8 eTheRNA
9.8.1 eTheRNA mRNA Vaccines and Therapeutics Basic Information
9.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Overview
9.8.3 eTheRNA mRNA Vaccines and Therapeutics Product Market Performance
9.8.4 eTheRNA Business Overview
9.8.5 eTheRNA Recent Developments
9.9 Ethris
9.9.1 Ethris mRNA Vaccines and Therapeutics Basic Information
9.9.2 Ethris mRNA Vaccines and Therapeutics Product Overview
9.9.3 Ethris mRNA Vaccines and Therapeutics Product Market Performance
9.9.4 Ethris Business Overview
9.9.5 Ethris Recent Developments
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology mRNA Vaccines and Therapeutics Basic Information
9.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Overview
9.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Market Performance
9.10.4 Tiba Biotechnology Business Overview
9.10.5 Tiba Biotechnology Recent Developments
10 MRNA VACCINES AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global mRNA Vaccines and Therapeutics Market Size Forecast
10.2 Global mRNA Vaccines and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccines and Therapeutics Market Size Forecast by Region
10.2.4 South America mRNA Vaccines and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccines and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global mRNA Vaccines and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.1.2 Global mRNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccines and Therapeutics by Type (2025-2030)
11.2 Global mRNA Vaccines and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccines and Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Vaccines and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA Vaccines and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Vaccines and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Vaccines and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines and Therapeutics as of 2022)
Table 10. Global Market mRNA Vaccines and Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Vaccines and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers mRNA Vaccines and Therapeutics Product Type
Table 13. Global mRNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Vaccines and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccines and Therapeutics Market Challenges
Table 22. Global mRNA Vaccines and Therapeutics Sales by Type (Kilotons)
Table 23. Global mRNA Vaccines and Therapeutics Market Size by Type (M USD)
Table 24. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Vaccines and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Vaccines and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global mRNA Vaccines and Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Application
Table 30. Global mRNA Vaccines and Therapeutics Market Size by Application
Table 31. Global mRNA Vaccines and Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Vaccines and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Table 35. Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Moderna Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 44. Moderna Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 45. Moderna Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Moderna Therapeutics Business Overview
Table 47. Moderna Therapeutics mRNA Vaccines and Therapeutics SWOT Analysis
Table 48. Moderna Therapeutics Recent Developments
Table 49. CureVac mRNA Vaccines and Therapeutics Basic Information
Table 50. CureVac mRNA Vaccines and Therapeutics Product Overview
Table 51. CureVac mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CureVac Business Overview
Table 53. CureVac mRNA Vaccines and Therapeutics SWOT Analysis
Table 54. CureVac Recent Developments
Table 55. Translate Bio mRNA Vaccines and Therapeutics Basic Information
Table 56. Translate Bio mRNA Vaccines and Therapeutics Product Overview
Table 57. Translate Bio mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Translate Bio mRNA Vaccines and Therapeutics SWOT Analysis
Table 59. Translate Bio Business Overview
Table 60. Translate Bio Recent Developments
Table 61. BioNTech mRNA Vaccines and Therapeutics Basic Information
Table 62. BioNTech mRNA Vaccines and Therapeutics Product Overview
Table 63. BioNTech mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioNTech Business Overview
Table 65. BioNTech Recent Developments
Table 66. Sangamo Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 67. Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 68. Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sangamo Therapeutics Business Overview
Table 70. Sangamo Therapeutics Recent Developments
Table 71. Argos Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 72. Argos Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 73. Argos Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Argos Therapeutics Business Overview
Table 75. Argos Therapeutics Recent Developments
Table 76. In-Cell-Art mRNA Vaccines and Therapeutics Basic Information
Table 77. In-Cell-Art mRNA Vaccines and Therapeutics Product Overview
Table 78. In-Cell-Art mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. In-Cell-Art Business Overview
Table 80. In-Cell-Art Recent Developments
Table 81. eTheRNA mRNA Vaccines and Therapeutics Basic Information
Table 82. eTheRNA mRNA Vaccines and Therapeutics Product Overview
Table 83. eTheRNA mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. eTheRNA Business Overview
Table 85. eTheRNA Recent Developments
Table 86. Ethris mRNA Vaccines and Therapeutics Basic Information
Table 87. Ethris mRNA Vaccines and Therapeutics Product Overview
Table 88. Ethris mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Ethris Business Overview
Table 90. Ethris Recent Developments
Table 91. Tiba Biotechnology mRNA Vaccines and Therapeutics Basic Information
Table 92. Tiba Biotechnology mRNA Vaccines and Therapeutics Product Overview
Table 93. Tiba Biotechnology mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Tiba Biotechnology Business Overview
Table 95. Tiba Biotechnology Recent Developments
Table 96. Global mRNA Vaccines and Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global mRNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific mRNA Vaccines and Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific mRNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa mRNA Vaccines and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global mRNA Vaccines and Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global mRNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global mRNA Vaccines and Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global mRNA Vaccines and Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global mRNA Vaccines and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Vaccines and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA Vaccines and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Vaccines and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Vaccines and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines and Therapeutics as of 2022)
Table 10. Global Market mRNA Vaccines and Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Vaccines and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers mRNA Vaccines and Therapeutics Product Type
Table 13. Global mRNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Vaccines and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Vaccines and Therapeutics Market Challenges
Table 22. Global mRNA Vaccines and Therapeutics Sales by Type (Kilotons)
Table 23. Global mRNA Vaccines and Therapeutics Market Size by Type (M USD)
Table 24. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Vaccines and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Vaccines and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global mRNA Vaccines and Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA Vaccines and Therapeutics Sales (Kilotons) by Application
Table 30. Global mRNA Vaccines and Therapeutics Market Size by Application
Table 31. Global mRNA Vaccines and Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Vaccines and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Table 35. Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA Vaccines and Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA Vaccines and Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Moderna Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 44. Moderna Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 45. Moderna Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Moderna Therapeutics Business Overview
Table 47. Moderna Therapeutics mRNA Vaccines and Therapeutics SWOT Analysis
Table 48. Moderna Therapeutics Recent Developments
Table 49. CureVac mRNA Vaccines and Therapeutics Basic Information
Table 50. CureVac mRNA Vaccines and Therapeutics Product Overview
Table 51. CureVac mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CureVac Business Overview
Table 53. CureVac mRNA Vaccines and Therapeutics SWOT Analysis
Table 54. CureVac Recent Developments
Table 55. Translate Bio mRNA Vaccines and Therapeutics Basic Information
Table 56. Translate Bio mRNA Vaccines and Therapeutics Product Overview
Table 57. Translate Bio mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Translate Bio mRNA Vaccines and Therapeutics SWOT Analysis
Table 59. Translate Bio Business Overview
Table 60. Translate Bio Recent Developments
Table 61. BioNTech mRNA Vaccines and Therapeutics Basic Information
Table 62. BioNTech mRNA Vaccines and Therapeutics Product Overview
Table 63. BioNTech mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. BioNTech Business Overview
Table 65. BioNTech Recent Developments
Table 66. Sangamo Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 67. Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 68. Sangamo Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sangamo Therapeutics Business Overview
Table 70. Sangamo Therapeutics Recent Developments
Table 71. Argos Therapeutics mRNA Vaccines and Therapeutics Basic Information
Table 72. Argos Therapeutics mRNA Vaccines and Therapeutics Product Overview
Table 73. Argos Therapeutics mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Argos Therapeutics Business Overview
Table 75. Argos Therapeutics Recent Developments
Table 76. In-Cell-Art mRNA Vaccines and Therapeutics Basic Information
Table 77. In-Cell-Art mRNA Vaccines and Therapeutics Product Overview
Table 78. In-Cell-Art mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. In-Cell-Art Business Overview
Table 80. In-Cell-Art Recent Developments
Table 81. eTheRNA mRNA Vaccines and Therapeutics Basic Information
Table 82. eTheRNA mRNA Vaccines and Therapeutics Product Overview
Table 83. eTheRNA mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. eTheRNA Business Overview
Table 85. eTheRNA Recent Developments
Table 86. Ethris mRNA Vaccines and Therapeutics Basic Information
Table 87. Ethris mRNA Vaccines and Therapeutics Product Overview
Table 88. Ethris mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Ethris Business Overview
Table 90. Ethris Recent Developments
Table 91. Tiba Biotechnology mRNA Vaccines and Therapeutics Basic Information
Table 92. Tiba Biotechnology mRNA Vaccines and Therapeutics Product Overview
Table 93. Tiba Biotechnology mRNA Vaccines and Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Tiba Biotechnology Business Overview
Table 95. Tiba Biotechnology Recent Developments
Table 96. Global mRNA Vaccines and Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global mRNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific mRNA Vaccines and Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific mRNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America mRNA Vaccines and Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa mRNA Vaccines and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa mRNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global mRNA Vaccines and Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global mRNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global mRNA Vaccines and Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global mRNA Vaccines and Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global mRNA Vaccines and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Vaccines and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccines and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global mRNA Vaccines and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global mRNA Vaccines and Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccines and Therapeutics Market Size by Country (M USD)
Figure 11. mRNA Vaccines and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Vaccines and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Vaccines and Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccines and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Vaccines and Therapeutics Market Share by Type
Figure 18. Sales Market Share of mRNA Vaccines and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Vaccines and Therapeutics by Type in 2023
Figure 20. Market Size Share of mRNA Vaccines and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Vaccines and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Vaccines and Therapeutics Market Share by Application
Figure 24. Global mRNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Vaccines and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global mRNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global mRNA Vaccines and Therapeutics Market Share by Application in 2023
Figure 28. Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA Vaccines and Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Vaccines and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 44. China mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA Vaccines and Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA Vaccines and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA Vaccines and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA Vaccines and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA Vaccines and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA Vaccines and Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of mRNA Vaccines and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Vaccines and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global mRNA Vaccines and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global mRNA Vaccines and Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Vaccines and Therapeutics Market Size by Country (M USD)
Figure 11. mRNA Vaccines and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Vaccines and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Vaccines and Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccines and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Vaccines and Therapeutics Market Share by Type
Figure 18. Sales Market Share of mRNA Vaccines and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Vaccines and Therapeutics by Type in 2023
Figure 20. Market Size Share of mRNA Vaccines and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Vaccines and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Vaccines and Therapeutics Market Share by Application
Figure 24. Global mRNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Vaccines and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global mRNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global mRNA Vaccines and Therapeutics Market Share by Application in 2023
Figure 28. Global mRNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA Vaccines and Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Vaccines and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 44. China mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA Vaccines and Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA Vaccines and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA Vaccines and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA Vaccines and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA Vaccines and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA Vaccines and Therapeutics Market Share Forecast by Application (2025-2030)
